The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Containers of Ozempic and Wegovy medications are seen at Children's Hospital in Aurora, Colo.. Some Minnesota school district leaders say the high cost of covering popular GLP-1 weight loss drugs ...

However, their high monthly costs — ranging from $1,000 to $1,500 — are placing considerable financial pressure on employer-sponsored healthcare plans. According to a 2024 survey by the Business Group ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...